Immix Biopharma Inc (IMMX)

Currency in USD
2.540
-0.110(-4.15%)
Closed·
After Hours
2.5400.000(0.00%)
·
IMMX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IMMX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.5002.775
52 wk Range
1.2603.200
Key Statistics
Prev. Close
2.54
Open
2.71
Day's Range
2.5-2.775
52 wk Range
1.26-3.2
Volume
252.69K
Average Volume (3m)
274.86K
1-Year Change
18.69%
Book Value / Share
0.35
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMMX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.000
Upside
+175.59%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Immix Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Immix Biopharma Inc Company Profile

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company’ lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Compare IMMX to Peers and Sector

Metrics to compare
IMMX
Peers
Sector
Relationship
P/E Ratio
−3.4x−3.5x−0.5x
PEG Ratio
−0.150.010.00
Price/Book
7.4x2.8x2.6x
Price / LTM Sales
-10.3x3.3x
Upside (Analyst Target)
164.2%190.7%43.5%
Fair Value Upside
Unlock1.8%6.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.000
(+175.59% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.15 / -0.23
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

IMMX Income Statement

People Also Watch

2.650
MBOT
+3.92%
3.430
IMRX
+1.78%
0.415
ADIL
-8.79%
1.830
IPA
+11.59%

FAQ

What Stock Exchange Does Immix Biopharma Trade On?

Immix Biopharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Immix Biopharma?

The stock symbol for Immix Biopharma is "IMMX."

What Is the Immix Biopharma Market Cap?

As of today, Immix Biopharma market cap is 70.74M.

What Is Immix Biopharma's Earnings Per Share (TTM)?

The Immix Biopharma EPS (TTM) is -0.70.

When Is the Next Immix Biopharma Earnings Date?

Immix Biopharma will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is IMMX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Immix Biopharma Stock Split?

Immix Biopharma has split 0 times.

How Many Employees Does Immix Biopharma Have?

Immix Biopharma has 20 employees.

What is the current trading status of Immix Biopharma (IMMX)?

As of 05 Aug 2025, Immix Biopharma (IMMX) is trading at a price of 2.54, with a previous close of 2.54. The stock has fluctuated within a day range of 2.50 to 2.78, while its 52-week range spans from 1.26 to 3.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.